Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

5.3%

1 terminated/withdrawn out of 19 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

Phase 1
7(77.8%)
Early Phase 1
1(11.1%)
N/A
1(11.1%)
9Total
Phase 1(7)
Early Phase 1(1)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (19)

Showing 19 of 19 trials
NCT07553767Early Phase 1Not Yet Recruiting

Efficacy and Safety of Pegylated Interferon Alpha-2β in Patients With Hepatitis B-related Hepatocellular Carcinoma After Radical Resection

Role: collaborator

NCT07377175Phase 1Recruiting

Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BSY001 After Single/Multiple Doses.

Role: collaborator

NCT06693362Phase 1Recruiting

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Study to Evaluate the Safety and Efficacy of Uterine Blood Mesenchymal Stem Cells Injection for the Treatment of Severe Pneumonia Caused by Viruses

Role: collaborator

NCT06331260Not Yet Recruiting

Assessment of AFP and PIVKA-II as Prognostic Indicators in Liver Transplantation for Hepatocellular Carcinoma

Role: collaborator

NCT06331273Not Yet Recruiting

Impact of "No-touch" Technique on the Outcome of Liver Transplantation for Hepatocellular Carcinoma

Role: collaborator

NCT06307158Completed

Influence of Intraoperative Blood Salvage and Autotransfusion on Tumor Recurrence After Deceased Donor Liver Transplantation

Role: collaborator

NCT06209775Completed

Impact of Perioperative Body Composition Abnormalities on Patient Outcomes After Liver Transplantation

Role: collaborator

NCT06188273Not Yet Recruiting

Impact of Skeletal Muscle Quality and Loss on the Outcome of Liver Transplantation

Role: collaborator

NCT06113744Phase 1Unknown

A Phase 1 Study to Evaluate the Safety and Immunogenicity of COVID-19 Vaccine

Role: collaborator

NCT05937178Recruiting

Real-world Study Optimizing Nucleotide-analogues

Role: collaborator

NCT05365724Phase 1Unknown

A Study to Evaluate the Safety and Immunogenicity of Omicron COVID-19 Vaccine (Vero Cell), Inactivated in Population 18 Years Old of Age and Above

Role: collaborator

NCT05251272Unknown

A Combined Model Based on Spleen Stiffness, Liver Stiffness and Platelets for Assessing Portal Hypertension in Compensated Cirrhosis (CHESS2202)

Role: collaborator

NCT05551884Unknown

Non-invasive Diagnosis of Portal Hypertension in Cirrhosis Based on Metabolomics Technology

Role: collaborator

NCT05052892Unknown

A Novel Spleen-dedicated Stiffness Measured by FibroScan to Evaluate Cirrhotic Portal Hypertension (CHESS2105)

Role: collaborator

NCT05707520Unknown

Long-term Benefit of MPA in Liver Transplantation

Role: collaborator

NCT05364047Phase 1Unknown

Clinical Trial of SARS-CoV-2 mRNA Vaccine in China

Role: collaborator

NCT03945799Phase 1Terminated

A Multicenter Study of Anlotinib in Hepatocellular Carcinoma (HCC) Patients at High Risk of Post Surgery Recurrence

Role: collaborator

NCT04309747Not ApplicableUnknown

A Prospective, Multicenter Clinical Trial of Safety and Effectiveness of Nanosecond Knife Ablation for Liver Cancer

Role: collaborator

NCT04035876Phase 1Unknown

Combination Camrelizumab (SHR-1210) and Apatinib for Downstaging/Bridging of HCC Before Liver Transplant

Role: collaborator

All 19 trials loaded